340B Drug Pricing Program
AMERICAN HOSPITAL ASSOCIATION, ET AL., APPELLANTS v. ALEX MICHAEL AZAR II, IN HIS OFFICIAL CAPACITY AS THE SECRETARY OF HEALTH AND HUMAN SERVICES AND UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES, APPELLEES
Appeal from the United States District Court for the District of Columbia (No. 1:17…
The AHA today submitted comments on the Department of Health and Human Services’ blueprint to lower drug prices and out-of-pocket costs.
AHA comments on the 340B section of the Department of Health and Human Services’ Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs.
The House Energy and Commerce Subcommittee on Health today hosted a hearing focused on the 340B drug savings program, including examining more than a dozen legislative proposals that would make changes to the program.
On behalf of our nearly 5,000 member hospitals, health systems and other health care organizations, including more than 1,900 hospitals that participate in the 340B drug savings program, and our clinician partners – including more than 270,000 affiliated physicians, 2 million nurses and other…
The 340B drug savings program must be reformed, Health and Human Services Secretary Alex Azar said today at a 340B conference in Washington, D.C.
The House Energy and Commerce Health Subcommittee today posted more than a dozen bills and discussion drafts related to the 340 drug savings program as it prepares to hold a July 11 hearing on improving the program.
In a report issued today, the Government Accountability Office recommended that the Health Resources and Services Administration take additional steps to ensure contract pharmacies comply with 340B drug savings program requirements.
The information below supplements the March 29, 2018 memorandum AHA’s outside counsel prepared regarding 340B claims submission during the legal challenge to the 2018 outpatient prospective payment system rule reducing reimbursements for 340B claims beginning Jan. 1, 2018.
The Senate Health, Education, Labor and Pensions Committee today held the third in a series of hearings examining the 340B drug savings program.
At the hearing, Capt. Krista Pedley, director of the Office of Pharmacy Affairs at the Health Resources and Services Administration, which oversees…